US Stock MarketDetailed Quotes

PRLD Prelude Therapeutics

Watchlist
  • 5.210
  • -0.560-9.71%
Close Aug 16 16:00 ET
286.68MMarket Cap-2943P/E (TTM)

Prelude Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
14.71%37.16M
17.96%34.34M
7.07%132.28M
11.96%37.38M
9.80%33.39M
9.97%32.4M
-3.87%29.12M
8.62%123.54M
1.14%33.39M
-1.39%30.41M
Selling and administrative expenses
3.00%7.66M
-4.77%6.93M
-5.76%28.88M
-6.24%7.05M
-5.23%7.12M
-8.82%7.43M
-2.49%7.28M
13.70%30.65M
-4.03%7.52M
-7.37%7.52M
-General and administrative expense
3.00%7.66M
-4.77%6.93M
-5.76%28.88M
-6.24%7.05M
-5.23%7.12M
-8.82%7.43M
-2.49%7.28M
13.70%30.65M
-4.03%7.52M
-7.37%7.52M
Research and development costs
18.20%29.51M
25.53%27.41M
11.31%103.39M
17.25%30.33M
14.73%26.26M
17.16%24.97M
-4.32%21.83M
7.04%92.89M
2.74%25.87M
0.74%22.89M
Operating profit
-14.71%-37.16M
-17.96%-34.34M
-7.07%-132.28M
-11.96%-37.38M
-9.80%-33.39M
-9.97%-32.4M
3.87%-29.12M
-8.62%-123.54M
-1.14%-33.39M
1.39%-30.41M
Net non-operating interest income expense
Other net income (expense)
23.23%2.42M
108.45%2.91M
28.92%10.45M
-9.27%4.3M
519.87%2.78M
-5.75%1.97M
69.74%1.4M
296.96%8.1M
2,723.81%4.74M
200.67%448K
Other non- operating income (expenses)
23.23%2.42M
108.45%2.91M
28.92%10.45M
-9.27%4.3M
519.87%2.78M
-5.75%1.97M
69.74%1.4M
296.96%8.1M
2,723.81%4.74M
200.67%448K
Income before tax
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
2.38%-29.96M
Income tax
Net income
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
2.38%-29.96M
Net income continuous Operations
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
2.38%-29.96M
Minority interest income
Net income attributable to the parent company
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
2.38%-29.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
2.38%-29.96M
Basic earnings per share
14.81%-0.46
27.59%-0.42
17.21%-2.02
21.67%-0.47
28.57%-0.45
6.90%-0.54
7.94%-0.58
-0.41%-2.44
15.49%-0.6
4.55%-0.63
Diluted earnings per share
14.81%-0.46
27.59%-0.42
17.21%-2.02
21.67%-0.47
28.57%-0.45
6.90%-0.54
7.94%-0.58
-0.41%-2.44
15.49%-0.6
4.55%-0.63
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 14.71%37.16M17.96%34.34M7.07%132.28M11.96%37.38M9.80%33.39M9.97%32.4M-3.87%29.12M8.62%123.54M1.14%33.39M-1.39%30.41M
Selling and administrative expenses 3.00%7.66M-4.77%6.93M-5.76%28.88M-6.24%7.05M-5.23%7.12M-8.82%7.43M-2.49%7.28M13.70%30.65M-4.03%7.52M-7.37%7.52M
-General and administrative expense 3.00%7.66M-4.77%6.93M-5.76%28.88M-6.24%7.05M-5.23%7.12M-8.82%7.43M-2.49%7.28M13.70%30.65M-4.03%7.52M-7.37%7.52M
Research and development costs 18.20%29.51M25.53%27.41M11.31%103.39M17.25%30.33M14.73%26.26M17.16%24.97M-4.32%21.83M7.04%92.89M2.74%25.87M0.74%22.89M
Operating profit -14.71%-37.16M-17.96%-34.34M-7.07%-132.28M-11.96%-37.38M-9.80%-33.39M-9.97%-32.4M3.87%-29.12M-8.62%-123.54M-1.14%-33.39M1.39%-30.41M
Net non-operating interest income expense
Other net income (expense) 23.23%2.42M108.45%2.91M28.92%10.45M-9.27%4.3M519.87%2.78M-5.75%1.97M69.74%1.4M296.96%8.1M2,723.81%4.74M200.67%448K
Other non- operating income (expenses) 23.23%2.42M108.45%2.91M28.92%10.45M-9.27%4.3M519.87%2.78M-5.75%1.97M69.74%1.4M296.96%8.1M2,723.81%4.74M200.67%448K
Income before tax -14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M2.38%-29.96M
Income tax
Net income -14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M2.38%-29.96M
Net income continuous Operations -14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M2.38%-29.96M
Minority interest income
Net income attributable to the parent company -14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M2.38%-29.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M2.38%-29.96M
Basic earnings per share 14.81%-0.4627.59%-0.4217.21%-2.0221.67%-0.4728.57%-0.456.90%-0.547.94%-0.58-0.41%-2.4415.49%-0.64.55%-0.63
Diluted earnings per share 14.81%-0.4627.59%-0.4217.21%-2.0221.67%-0.4728.57%-0.456.90%-0.547.94%-0.58-0.41%-2.4415.49%-0.64.55%-0.63
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg